Cell Dissociation Market by Product (Enzymatic (Trypsin), Non-enzymatic, Instruments & Accessories), Type (Tissue Dissociation, Cell Detachment), Tissue (Connective, Epithelial), End User (Pharma and Biotech, Research institutes)- Global Industry Analysis, Share ,Growth ,Regional Outlook And Forecasts, 2021-2027

The global Cell Dissociation market gathered revenue around USD 250 million in 2020 and market is set to grow USD 600 million by the end of 2027 and is estimated to expand at a modest CAGR of 16.1% during the prediction period 2021 to 2027. Growth of the market is driven mainly by increasing prevalence of cell based research, the increasing number of pharmaceutical and biotechnology companies.

This research report purposes at stressing the most lucrative growth prospects. The aim of the research report is to provide an inclusive valuation of the Cell Dissociation market and it encompasses thoughtful visions, actualities, industry-validated market findings, historic data, and prognoses by means of appropriate set of assumptions and practice. Global Cell Dissociation market report aids in comprehending market structure and dynamics by recognizing and scrutinizing the market sectors and predicted the global market outlook.

Emerging markets, such as China, India, and Brazil, are expected to offer significant growth opportunities for players operating in the cell dissociation market. These markets are expected to witness high growth in the coming years owing to the increasing R&D activities in the life sciences sector in these countries. For instance, pharmaceutical companies based in India are making significant investments in R&D to introduce new drugs into the market. 

COVID-19 Impact Assessment on Market Landscape

The report comprises the scrutiny of COVID-19 lock-down impact on the income of market leaders, disrupters and followers. Since lock down was instigated differently in diverse regions and nations, influence of same is also dissimilar across various industry verticals. The research report offers present short-term and long-term influence on the market to assist market participants across value chain makers to formulate the framework for short term and long-lasting tactics for recovery and by region.

Cell Dissociation market report empower readers with all-inclusive market intelligence and offers a granular outline of the market they are operational in. Further this research study delivers exceptional combination of tangible perceptions and qualitative scrutiny to aid companies accomplishes sustainable growth. This report employs industry-leading research practices and tools to assemble all-inclusive market studies, intermingled with pertinent data. Additionally, this report also emphases on the competitive examination of crucial players by analyzing their product portfolio, pricing, gross margins, financial position, growth approaches, and regional occurrence.

North America accounted for the largest share of the cell dissociation market in 2020

Based on the region, the cell dissociation market is segmented into North America, Europe, Asia Pacific, and the Rest of the World (RoW). In 2020, North America accounted for the largest share of the cell dissociation market. The large share of North America can can primarily be attributed to the increasing research in pharmaceutical and biotechnology industries and the strong presence of major market players in this region.

Competitive Rivalry

Foremost players in the market are attentive on adopting corporation strategies to enhance their market share. Some of the prominent tactics undertaken by leading market participants in order to sustain the fierce market completion include collaborations, acquisitions, substantial spending in R&D and the improvement of new-fangled products or reforms among others.

Significant Market Participants Operational in the Cell Dissociation Market are: Thermo Fisher Scientific (US), Becton, Dickinson and Company (US), Roche Diagnostics (Switzerland), Cytiva (a part of Danaher Corporation) (US), STEMCELL Technologies (Canada), Miltenyi Biotec (Germany), PromoCell GmbH (Germany), AcceGen(US), VitaCyte (US), Alstem (US), Biological Industries (Israel), Gemini Bio (US), Innovative Cell Technologies (US), Central Drug House (India), Worthington Biochemical Corporation (US), Capricorn Scientific (Germany), Abeomics (US), Genlantis (US), and Neuromics (US)

Unravelling the Critical Segments

This research report offers market revenue, sales volume, production assessment and prognoses by classifying it on the basis of various aspects including product type, application/end-user, and region. Further, this research study investigates market size, production, consumption and its development trends at global, regional, and country level for period 2017 to 2027 and covers subsequent region in its scope:

by Product

  • Enzymatic Dissociation Products
    • Collagenase
    • Trypsin
    • Papain
    • Elastase
    • DNase
    • Hyaluronidase
    • Other Enzymes
  • Enzymatic Dissociation Products
  • Instruments

by Tissue

  • Connective Tissues
  • Epithelial Tissues
  • Other type tissues (skeletal and muscles tisues)

by Type

  • Tissue dissociation
  • Cell detachment

by End User

  • Pharmaceutical and Biotechnology companies
  • Research and Academics
  • other end users

By Geography

North America

  • U.S.
  • Canada

Europe

  • Germany
  • France
  • United Kingdom
  • Rest of Europe

Asia Pacific

  • China
  • Japan
  • India
  • Southeast Asia
  • Rest of Asia Pacific

Latin America

  • Brazil
  • Rest of Latin America

Middle East & Africa (MEA)

  • GCC
  • North Africa
  • South Africa
  • Rest of Middle East & Africa

Chapter 1.    Introduction

1.1.  Research Objective

1.2.  Scope of the Study

1.3.  Definition

Chapter 2.    Research Methodology

2.1.  Research Approach

2.2.  Data Sources

2.3.  Assumptions & Limitations

Chapter 3.    Executive Summary

3.1.  Market Snapshot

Chapter 4.    Market Variables and Scope

4.1.  Introduction

4.2.  Market Classification and Scope

4.3.  Industry Value Chain Analysis

4.3.1.     Raw Material Procurement Analysis

4.3.2.     Sales and Distribution Channel Analysis

4.3.3.     Downstream Buyer Analysis

Chapter 5.    Market Dynamics Analysis and Trends

5.1.  Market Dynamics

5.1.1.     Market Drivers

5.1.2.     Market Restraints

5.1.3.     Market Opportunities

5.2.  Porter’s Five Forces Analysis

5.2.1.     Bargaining power of suppliers

5.2.2.     Bargaining power of buyers

5.2.3.     Threat of substitute

5.2.4.     Threat of new entrants

5.2.5.     Degree of competition

Chapter 6.    Competitive Landscape

6.1.1.     Company Market Share/Positioning Analysis

6.1.2.     Key Strategies Adopted by Players

6.1.3.     Vendor Landscape

6.1.3.1.          List of Suppliers

6.1.3.2.          List of Buyers

Chapter 7.    Global  Cell Dissociation Market, By Product

7.1.   Cell Dissociation  Market, by Product, 2021-2027

7.1.1.     Enzymatic Dissociation Products

7.1.1.1.          Market Revenue and Forecast (2016-2027)

7.1.2.     Collagenase

7.1.2.1.          Market Revenue and Forecast (2016-2027)

7.1.3.     Trypsin

7.1.3.1.          Market Revenue and Forecast (2016-2027)

7.1.4.     Papain

7.1.4.1.          Market Revenue and Forecast (2016-2027)

7.1.5.     Elastase

7.1.5.1.          Market Revenue and Forecast (2016-2027)

7.1.6.     DNase

7.1.6.1.          Market Revenue and Forecast (2016-2027)

7.1.7.     Hyaluronidase

7.1.7.1.          Market Revenue and Forecast (2016-2027)

7.1.8.     Other Enzymes

7.1.8.1.          Market Revenue and Forecast (2016-2027)

7.1.9.     Enzymatic Dissociation Products

7.1.9.1.          Market Revenue and Forecast (2016-2027)

7.1.10.  Instruments

7.1.10.1.       Market Revenue and Forecast (2016-2027)

Chapter 8.    Global  Cell Dissociation Market, By Tissue

8.1.   Cell Dissociation  Market, by Tissue, 2021-2027

8.1.1.     Application 1

8.1.1.1.          Market Revenue and Forecast (2016-2027)

8.1.2.     Application 2

8.1.2.1.          Market Revenue and Forecast (2016-2027)

8.1.3.     Application 3

8.1.3.1.          Market Revenue and Forecast (2016-2027)

8.1.4.     Application 4

8.1.4.1.          Market Revenue and Forecast (2016-2027)

Chapter 9.    Global  Cell Dissociation Market, By Type

9.1.   Cell Dissociation  Market, by Type, 2021-2027

9.1.1.     End User 1

9.1.1.1.          Market Revenue and Forecast (2016-2027)

9.1.2.     End User 2

9.1.2.1.          Market Revenue and Forecast (2016-2027)

9.1.3.     End User 3

9.1.3.1.          Market Revenue and Forecast (2016-2027)

9.1.4.     End User 4

9.1.4.1.          Market Revenue and Forecast (2016-2027)

Chapter 10.Global  Cell Dissociation Market, By End User

10.1.           Cell Dissociation  Market, by End User, 2021-2027

10.1.1.  Capacitor 1

10.1.1.1.       Market Revenue and Forecast (2016-2027)

10.1.2.  Capacitor 2

10.1.2.1.       Market Revenue and Forecast (2016-2027)

10.1.3.  Capacitor 3

10.1.3.1.       Market Revenue and Forecast (2016-2027)

10.1.4.  Capacitor 4

10.1.4.1.       Market Revenue and Forecast (2016-2027)

Chapter 11.Global  Cell Dissociation  Market, Regional Estimates and Trend Forecast

11.1.          North America

11.1.1.  Market Revenue and Forecast, by Product (2016-2027)

11.1.2.  Market Revenue and Forecast, by Tissue (2016-2027)

11.1.3.  Market Revenue and Forecast, by Type (2016-2027)

11.1.4.  Market Revenue and Forecast, by End User (2016-2027)

11.1.5.  U.S.

11.1.5.1.       Market Revenue and Forecast, by Product (2016-2027)

11.1.5.2.       Market Revenue and Forecast, by Tissue (2016-2027)

11.1.5.3.       Market Revenue and Forecast, by Type (2016-2027)

11.1.5.4.       Market Revenue and Forecast, by End User (2016-2027)

11.1.6.  Rest of North America

11.1.6.1.       Market Revenue and Forecast, by Product (2016-2027)

11.1.6.2.       Market Revenue and Forecast, by Tissue (2016-2027)

11.1.6.3.       Market Revenue and Forecast, by Type (2016-2027)

11.1.6.4.       Market Revenue and Forecast, by End User (2016-2027)

11.2.          Europe

11.2.1.  Market Revenue and Forecast, by Product (2016-2027)

11.2.2.  Market Revenue and Forecast, by Tissue (2016-2027)

11.2.3.  Market Revenue and Forecast, by Type (2016-2027)

11.2.4.  Market Revenue and Forecast, by End User (2016-2027)

11.2.5.  UK

11.2.5.1.       Market Revenue and Forecast, by Product (2016-2027)

11.2.5.2.       Market Revenue and Forecast, by Tissue (2016-2027)

11.2.5.3.       Market Revenue and Forecast, by Type (2016-2027)

11.2.5.4.       Market Revenue and Forecast, by End User (2016-2027)

11.2.6.  Germany

11.2.6.1.       Market Revenue and Forecast, by Product(2016-2027)

11.2.6.2.       Market Revenue and Forecast, by Tissue (2016-2027)

11.2.6.3.       Market Revenue and Forecast, by Type (2016-2027)

11.2.6.4.       Market Revenue and Forecast, by End User (2016-2027)

11.2.7.  France

11.2.7.1.       Market Revenue and Forecast, by Product (2016-2027)

11.2.7.2.       Market Revenue and Forecast, by Tissue (2016-2027)

11.2.7.3.       Market Revenue and Forecast, by Type (2016-2027)

11.2.7.4.       Market Revenue and Forecast, by End User (2016-2027)

11.2.8.  Rest of Europe

11.2.8.1.       Market Revenue and Forecast, by Product (2016-2027)

11.2.8.2.       Market Revenue and Forecast, by Tissue (2016-2027)

11.2.8.3.       Market Revenue and Forecast, by Type (2016-2027)

11.2.8.4.       Market Revenue and Forecast, by End User (2016-2027)

11.3.          APAC

11.3.1.  Market Revenue and Forecast, by Product (2016-2027)

11.3.2.  Market Revenue and Forecast, by Tissue (2016-2027)

11.3.3.  Market Revenue and Forecast, by Type (2016-2027)

11.3.4.  Market Revenue and Forecast, by End User (2016-2027)

11.3.5.  India

11.3.5.1.       Market Revenue and Forecast, by Product (2016-2027)

11.3.5.2.       Market Revenue and Forecast, by Tissue (2016-2027)

11.3.5.3.       Market Revenue and Forecast, by Type (2016-2027)

11.3.5.4.       Market Revenue and Forecast, by End User (2016-2027)

11.3.6.  China

11.3.6.1.       Market Revenue and Forecast, by Product (2016-2027)

11.3.6.2.       Market Revenue and Forecast, by Tissue (2016-2027)

11.3.6.3.       Market Revenue and Forecast, by Type (2016-2027)

11.3.6.4.       Market Revenue and Forecast, by End User (2016-2027)

11.3.7.  Japan

11.3.7.1.       Market Revenue and Forecast, by Product (2016-2027)

11.3.7.2.       Market Revenue and Forecast, by Tissue (2016-2027)

11.3.7.3.       Market Revenue and Forecast, by Type (2016-2027)

11.3.7.4.       Market Revenue and Forecast, by End User (2016-2027)

11.3.8.  Rest of APAC

11.3.8.1.       Market Revenue and Forecast, by Product (2016-2027)

11.3.8.2.       Market Revenue and Forecast, by Tissue (2016-2027)

11.3.8.3.       Market Revenue and Forecast, by Type (2016-2027)

11.3.8.4.       Market Revenue and Forecast, by End User (2016-2027)

11.4.          MEA

11.4.1.  Market Revenue and Forecast, by Product (2016-2027)

11.4.2.  Market Revenue and Forecast, by Tissue (2016-2027)

11.4.3.  Market Revenue and Forecast, by Type (2016-2027)

11.4.4.  Market Revenue and Forecast, by End User (2016-2027)

11.4.5.  GCC

11.4.5.1.       Market Revenue and Forecast, by Product (2016-2027)

11.4.5.2.       Market Revenue and Forecast, by Tissue (2016-2027)

11.4.5.3.       Market Revenue and Forecast, by Type (2016-2027)

11.4.5.4.       Market Revenue and Forecast, by End User (2016-2027)

11.4.6.  North Africa

11.4.6.1.       Market Revenue and Forecast, by Product (2016-2027)

11.4.6.2.       Market Revenue and Forecast, by Tissue (2016-2027)

11.4.6.3.       Market Revenue and Forecast, by Type (2016-2027)

11.4.6.4.       Market Revenue and Forecast, by End User (2016-2027)

11.4.7.  South Africa

11.4.7.1.       Market Revenue and Forecast, by Product (2016-2027)

11.4.7.2.       Market Revenue and Forecast, by Tissue (2016-2027)

11.4.7.3.       Market Revenue and Forecast, by Type (2016-2027)

11.4.7.4.       Market Revenue and Forecast, by End User (2016-2027)

11.4.8.  Rest of MEA

11.4.8.1.       Market Revenue and Forecast, by Product (2016-2027)

11.4.8.2.       Market Revenue and Forecast, by Tissue (2016-2027)

11.4.8.3.       Market Revenue and Forecast, by Type (2016-2027)

11.4.8.4.       Market Revenue and Forecast, by End User (2016-2027)

11.5.          Latin America

11.5.1.  Market Revenue and Forecast, by Product (2016-2027)

11.5.2.  Market Revenue and Forecast, by Tissue (2016-2027)

11.5.3.  Market Revenue and Forecast, by Type (2016-2027)

11.5.4.  Market Revenue and Forecast, by End User (2016-2027)

11.5.5.  Brazil

11.5.5.1.       Market Revenue and Forecast, by Product (2016-2027)

11.5.5.2.       Market Revenue and Forecast, by Tissue (2016-2027)

11.5.5.3.       Market Revenue and Forecast, by Type (2016-2027)

11.5.5.4.       Market Revenue and Forecast, by End User (2016-2027)

11.5.6.  Rest of LATAM

11.5.6.1.       Market Revenue and Forecast, by Product (2016-2027)

11.5.6.2.       Market Revenue and Forecast, by Tissue (2016-2027)

11.5.6.3.       Market Revenue and Forecast, by Type (2016-2027)

11.5.6.4.       Market Revenue and Forecast, by End User (2016-2027)

Chapter 12.   Company Profiles

12.1.                 Thermo Fisher Scientific

12.1.1.  Company Overview

12.1.2.  Product Offerings

12.1.3.  Financial Performance

12.1.4.  Recent Initiatives

12.2.                 Becton, Dickinson and Company

12.2.1.  Company Overview

12.2.2.  Product Offerings

12.2.3.  Financial Performance

12.2.4.  Recent Initiatives

12.3.                 Roche Diagnostics

12.3.1.  Company Overview

12.3.2.  Product Offerings

12.3.3.  Financial Performance

12.3.4.  Recent Initiatives

12.4.                 Cytiva

12.4.1.  Company Overview

12.4.2.  Product Offerings

12.4.3.  Financial Performance

12.4.4.  Recent Initiatives

12.5.                 STEMCELL Technologies

12.5.1.  Company Overview

12.5.2.  Product Offerings

12.5.3.  Financial Performance

12.5.4.  Recent Initiatives

12.6.                 Miltenyi Biotec

12.6.1.  Company Overview

12.6.2.  Product Offerings

12.6.3.  Financial Performance

12.6.4.  Recent Initiatives

12.7.                 PromoCell GmbH

12.7.1.  Company Overview

12.7.2.  Product Offerings

12.7.3.  Financial Performance

12.7.4.  Recent Initiatives

12.8.                 AcceGen

12.8.1.  Company Overview

12.8.2.  Product Offerings

12.8.3.  Financial Performance

12.8.4.  Recent Initiatives

12.9.                 VitaCyte

12.9.1.  Company Overview

12.9.2.  Product Offerings

12.9.3.  Financial Performance

12.9.4.  Recent Initiatives

12.10.              Alstem

12.10.1.                   Company Overview

12.10.2.                   Product Offerings

12.10.3.                   Financial Performance

12.10.4.                   Recent Initiatives

Chapter 13.   Research Methodology

13.1.                 Primary Research

13.2.                 Secondary Research

13.3.                 Assumptions

Chapter 14.   Appendix

14.1.                 About Us

14.2.                 Glossary of Terms

Proceed To Buy

USD 4500
USD 3900
USD 1900
USD 1200

Customization Offered

  • check-img Cross-segment Market Size and Analysis for Mentioned Segments
  • check-imgAdditional Company Profiles (Upto 5 With No Cost)
  • check-img Additional Countries (Apart From Mentioned Countries)
  • check-img Country/Region-specific Report
  • check-img Go To Market Strategy
  • check-imgRegion Specific Market Dynamics
  • check-imgRegion Level Market Share
  • check-img Import Export Analysis
  • check-imgProduction Analysis
  • check-imgOthers